The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer.

In this retrospective histologic study, galectin-3 had a sensitivity of 92% (22/24) for papillary thyroid carcinoma and 44% (4/9) for follicular thyroid carcinoma. Thyroid peroxidase (TPO) had a sensitivity of 50% (12/24) for papillary and 11% (1/11) for follicular carcinoma. The combination of galectin-3 and TPO had a sensitivity of 96% (23/24) for papillary and 44% (4/9) for follicular carcinoma. From a prognostic standpoint, of patients whose papillary carcinomas expressed both markers, all became free of disease. Of those whose papillary carcinomas expressed galectin-3 but not TPO, 57% (4/7) became free of disease, 29% (2/7) had persistent disease, and 14% (1/7) had progressive disease. This study confirms previous observations that galectin-3 alone is highly sensitive for papillary carcinoma but not adequately sensitive for follicular carcinoma. TPO alone is not adequately sensitive for the evaluation of any thyroid lesion. The combination of galectin-3 and TPO is complementary as a diagnostic and prognostic tool for patients with papillary carcinoma.

[1]  J. Henry,et al.  Thyroperoxidase immunodetection for the diagnosis of malignancy on fine-needle aspiration of thyroid nodules , 1994, World Journal of Surgery.

[2]  S. Chevret,et al.  Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma. , 2003, Human pathology.

[3]  G. Winkler,et al.  The investigation of galectin-3 in diseases of the thyroid gland. , 2003, European journal of endocrinology.

[4]  Z. Baloch,et al.  Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions. , 2002, Archives of pathology & laboratory medicine.

[5]  M. Hirokawa,et al.  Observer Variation of Encapsulated Follicular Lesions of the Thyroid Gland , 2002, The American journal of surgical pathology.

[6]  John L. Wang,et al.  Intracellular functions of galectins. , 2002, Biochimica et biophysica acta.

[7]  Isabelle Camby,et al.  Galectins and cancer. , 2002, Biochimica et biophysica acta.

[8]  B. Haugen,et al.  Towards improving the utility of fine‐needle aspiration biopsy for the diagnosis of thyroid tumours , 2002, Clinical endocrinology.

[9]  P. De Giuli,et al.  Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. , 2001, The Journal of clinical endocrinology and metabolism.

[10]  A. Vecchione,et al.  Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions , 2001, The Lancet.

[11]  S. Natsugoe,et al.  Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation. , 2000, Human pathology.

[12]  N. Tinari,et al.  Galectin‐3 overexpression protects from apoptosis by improving cell adhesion properties , 2000, International journal of cancer.

[13]  A. Raz,et al.  Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. , 1999, Cancer research.

[14]  P. De Giuli,et al.  Galectin-3 is a presurgical marker of human thyroid carcinoma. , 1998, Cancer research.

[15]  S. Savin,et al.  Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. , 1998, Anticancer research.

[16]  L. Baum,et al.  Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death , 1998, Journal of Molecular Medicine.

[17]  E. Campo,et al.  GALECTIN‐3 AND LAMININ EXPRESSION IN NEOPLASTIC AND NON‐NEOPLASTIC THYROID TISSUE , 1997, The Journal of pathology.

[18]  D. Menzies,et al.  Evaluation of the monoclonal antibody antithyroperoxidase MoAb47 in the diagnostic decision of cold thyroid nodules by fine-needle aspiration. , 1997, Pathology, research and practice.

[19]  Riyao Yang,et al.  Expression of galectin-3 modulates T-cell growth and apoptosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Pluot,et al.  Quantitative cytology and thyroperoxidase immunochemistry: new tools in evaluating thyroid nodules by fine-needle aspiration. , 1996, Cancer detection and prevention.

[21]  V. Vasko,et al.  Fine-needle aspiration of thyroid follicular neoplasm: diagnostic use of thyroid peroxidase immunocytochemistry with monoclonal antibody 47. , 1994, Surgery.

[22]  L. Skoog,et al.  Thyroid peroxidase immunodetection as a tool to assist diagnosis of thyroid nodules on fine-needle aspiration biopsy. , 1994, European journal of endocrinology.

[23]  G. Masarotto,et al.  Histological Evaluation of Thyroid Carcinomas: Reproducibility of the «Who» Classification , 1993, Tumori.

[24]  K. Franssila,et al.  Observer Variation in Histologic Classification of Thyroid Cancer , 1978, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.